DIBENIL Drug Patent Profile
✉ Email this page to a colleague
When do Dibenil patents expire, and what generic alternatives are available?
Dibenil is a drug marketed by Cenci and is included in one NDA.
The generic ingredient in DIBENIL is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dibenil
A generic version of DIBENIL was approved as diphenhydramine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIBENIL?
- What are the global sales for DIBENIL?
- What is Average Wholesale Price for DIBENIL?
Summary for DIBENIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Patent Applications: | 4,368 |
| DailyMed Link: | DIBENIL at DailyMed |
US Patents and Regulatory Information for DIBENIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cenci | DIBENIL | diphenhydramine hydrochloride | ELIXIR;ORAL | 088304-001 | Dec 16, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
